Matches in Nanopublications for { ?s ?p "[Moreover, pretreatment of U373 with a cSrc inhibitor (PP2), a PI3K inhibitor (LY294002), an ERK inhibitor (PD98059), or a p38 MAPK inhibitor (SB203580) but not a JNK inhibitor (SP600125) significantly reduced the magnolol-induced increases of p27/Kip1 protein levels and apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 14 of
14
with 100 items per page.
- assertion description "[Moreover, pretreatment of U373 with a cSrc inhibitor (PP2), a PI3K inhibitor (LY294002), an ERK inhibitor (PD98059), or a p38 MAPK inhibitor (SB203580) but not a JNK inhibitor (SP600125) significantly reduced the magnolol-induced increases of p27/Kip1 protein levels and apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP624811.RAWmyc17vBAqkx5y41gcfcnvkAkt98mFV5l2XV7dQwKl4130_assertion description "[Moreover, pretreatment of U373 with a cSrc inhibitor (PP2), a PI3K inhibitor (LY294002), an ERK inhibitor (PD98059), or a p38 MAPK inhibitor (SB203580) but not a JNK inhibitor (SP600125) significantly reduced the magnolol-induced increases of p27/Kip1 protein levels and apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624811.RAWmyc17vBAqkx5y41gcfcnvkAkt98mFV5l2XV7dQwKl4130_provenance.
- NP623675.RAYkck-mqgvHsa2QSBBgbp0EZX5J1MOCGvAHIVtTt99gw130_assertion description "[Moreover, pretreatment of U373 with a cSrc inhibitor (PP2), a PI3K inhibitor (LY294002), an ERK inhibitor (PD98059), or a p38 MAPK inhibitor (SB203580) but not a JNK inhibitor (SP600125) significantly reduced the magnolol-induced increases of p27/Kip1 protein levels and apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623675.RAYkck-mqgvHsa2QSBBgbp0EZX5J1MOCGvAHIVtTt99gw130_provenance.
- assertion description "[Moreover, pretreatment of U373 with a cSrc inhibitor (PP2), a PI3K inhibitor (LY294002), an ERK inhibitor (PD98059), or a p38 MAPK inhibitor (SB203580) but not a JNK inhibitor (SP600125) significantly reduced the magnolol-induced increases of p27/Kip1 protein levels and apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Moreover, pretreatment of U373 with a cSrc inhibitor (PP2), a PI3K inhibitor (LY294002), an ERK inhibitor (PD98059), or a p38 MAPK inhibitor (SB203580) but not a JNK inhibitor (SP600125) significantly reduced the magnolol-induced increases of p27/Kip1 protein levels and apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Moreover, pretreatment of U373 with a cSrc inhibitor (PP2), a PI3K inhibitor (LY294002), an ERK inhibitor (PD98059), or a p38 MAPK inhibitor (SB203580) but not a JNK inhibitor (SP600125) significantly reduced the magnolol-induced increases of p27/Kip1 protein levels and apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Moreover, pretreatment of U373 with a cSrc inhibitor (PP2), a PI3K inhibitor (LY294002), an ERK inhibitor (PD98059), or a p38 MAPK inhibitor (SB203580) but not a JNK inhibitor (SP600125) significantly reduced the magnolol-induced increases of p27/Kip1 protein levels and apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Moreover, pretreatment of U373 with a cSrc inhibitor (PP2), a PI3K inhibitor (LY294002), an ERK inhibitor (PD98059), or a p38 MAPK inhibitor (SB203580) but not a JNK inhibitor (SP600125) significantly reduced the magnolol-induced increases of p27/Kip1 protein levels and apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1056629.RART1F-SajYn5Ks7XXmRU1UA9PlqqEqZ5V9E_fyvGiUIY130_assertion description "[Moreover, pretreatment of U373 with a cSrc inhibitor (PP2), a PI3K inhibitor (LY294002), an ERK inhibitor (PD98059), or a p38 MAPK inhibitor (SB203580) but not a JNK inhibitor (SP600125) significantly reduced the magnolol-induced increases of p27/Kip1 protein levels and apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1056629.RART1F-SajYn5Ks7XXmRU1UA9PlqqEqZ5V9E_fyvGiUIY130_provenance.
- NP622364.RAjFe6rxMCfMohToIHBgj5Ihrq9YCRg3uFBhNIoaWBsnk130_assertion description "[Moreover, pretreatment of U373 with a cSrc inhibitor (PP2), a PI3K inhibitor (LY294002), an ERK inhibitor (PD98059), or a p38 MAPK inhibitor (SB203580) but not a JNK inhibitor (SP600125) significantly reduced the magnolol-induced increases of p27/Kip1 protein levels and apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622364.RAjFe6rxMCfMohToIHBgj5Ihrq9YCRg3uFBhNIoaWBsnk130_provenance.
- NP1056631.RApp3VwGEbXOfD6W1OHEUo-quOA_KZ7wgXJfN0VojHEAo130_assertion description "[Moreover, pretreatment of U373 with a cSrc inhibitor (PP2), a PI3K inhibitor (LY294002), an ERK inhibitor (PD98059), or a p38 MAPK inhibitor (SB203580) but not a JNK inhibitor (SP600125) significantly reduced the magnolol-induced increases of p27/Kip1 protein levels and apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1056631.RApp3VwGEbXOfD6W1OHEUo-quOA_KZ7wgXJfN0VojHEAo130_provenance.
- NP1056633.RAsfGDRMzGt02zJwmE9hn8tAzNB-YCrjphsMIuBNlQMBI130_assertion description "[Moreover, pretreatment of U373 with a cSrc inhibitor (PP2), a PI3K inhibitor (LY294002), an ERK inhibitor (PD98059), or a p38 MAPK inhibitor (SB203580) but not a JNK inhibitor (SP600125) significantly reduced the magnolol-induced increases of p27/Kip1 protein levels and apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1056633.RAsfGDRMzGt02zJwmE9hn8tAzNB-YCrjphsMIuBNlQMBI130_provenance.
- NP1056637.RAoHfTc_5WsKLASakWW9OjKuP4cZ3SuebHeKObwg8YdFc130_assertion description "[Moreover, pretreatment of U373 with a cSrc inhibitor (PP2), a PI3K inhibitor (LY294002), an ERK inhibitor (PD98059), or a p38 MAPK inhibitor (SB203580) but not a JNK inhibitor (SP600125) significantly reduced the magnolol-induced increases of p27/Kip1 protein levels and apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1056637.RAoHfTc_5WsKLASakWW9OjKuP4cZ3SuebHeKObwg8YdFc130_provenance.
- NP620943.RA5JQnPqcvGaYqk_gkcDoMT2yoUQNWgdnlN_nn9cKUrVI130_assertion description "[Moreover, pretreatment of U373 with a cSrc inhibitor (PP2), a PI3K inhibitor (LY294002), an ERK inhibitor (PD98059), or a p38 MAPK inhibitor (SB203580) but not a JNK inhibitor (SP600125) significantly reduced the magnolol-induced increases of p27/Kip1 protein levels and apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620943.RA5JQnPqcvGaYqk_gkcDoMT2yoUQNWgdnlN_nn9cKUrVI130_provenance.